The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
Study: Adding GLP1RA to T2D Therapy Linked With Lower MACE In Older Patients Without CVDMay 8th 2023
Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.
Youth Diabetes Risk Perception Not Associated With Engagement in Risk-Reducing BehaviorsMay 5th 2023
Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.
Researchers Develop Predictive Model for Kidney Function Decline in Adults With T2DApril 7th 2023
Researchers developed a reliable prediction model for kidney function decline in adults with type 2 diabetes and early to moderately progressed chronic kidney disease, which was externally validated and made publicly available via a web-based application.
Rising Gestational Diabetes Rates Could Be Result of Changes in Screening PracticesMarch 25th 2023
An analysis of more than 500,000 pregnancies over a 15-year period suggests much of the increase in gestational diabetes rates observed during the study period can be attributed to changes in screening practices.
Co-occurring Diabetes and Tooth Loss Linked to Worse, Faster Cognitive DeclineMarch 15th 2023
New research suggests older adults with both diabetes and edentulism are more likely to experience worse and faster cognitive decline compared with adults without either condition and adults older in age.
HALO Misses End Point, but Optimism Remains for Baxdrostat in Resistant HypertensionMarch 5th 2023
Baxdrostat is a highly selective aldosterone synthase inhibitor; phase 1 studies showed that the therapy caused a sustained, dose-dependent reduction in plasma aldosterone by more than 70% without reducing cortisol.
How Rising Insulin Costs Impacted Uninsured PopulationsFebruary 23rd 2023
Researchers looked at trends in insulin usage and expenditure among insured and uninsured populations with diabetes, accounting for how the expansion of Medicaid under the Affordable Care Act may have affected these trends.
Adults With Diabetes in High-Deductible Health Plans More Likely to Have Severe HyperglycemiaJanuary 26th 2023
Adults with diabetes who were forced to switch from an employer-sponsored health plan to a high-deductible health plan (HDHP) were 25% more likely to require an emergency department (ED) or hospital visit for hyperglycemia, but not for hypoglycemia, than those who did not switch plans.
What We’re Reading: Eli Lilly to Expand Diabetes Drug Plant; Providers Billing for Emails; Gallup Poll on Universal Health CareJanuary 24th 2023
Eli Lilly will tack on $450 million more to increase capacity in a diabetes drug plant in light of shortages; patients emailing and messaging medical providers online might be charged; 57% of adults in a recent survey think that the federal government should secure health care coverage for all Americans.
Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care
Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.
Lifestyle Intervention May Help Reduce T2D Risk in Women With Prior Gestational DiabetesJanuary 6th 2023
A review showed lifestyle intervention was linked to a 24% reduction in type 2 diabetes (T2D) incidence among women with prior gestational diabetes, compared with standard of care.
Contributor: Health Systems Will Need a Tech Transformation to Prepare for CMS Glycemia MeasuresJanuary 2nd 2023
With data collection beginning on January 1, 2023, most health systems are not prepared for CMS’ new glycemia measures, and those that are will likely be floored by the results, according to the chief medical officer at Glytec.